<html>
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<style type="text/css">
.txt { white-space:nowrap; }
.f0 { font-family:sans-serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff0; src: url("0.otf"); }
.f1 { font-family:ff0,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff2; src: url("2.otf"); }
.f2 { font-family:ff2,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff7; src: url("7.otf"); }
.f3 { font-family:ff7,serif; font-weight:normal; font-style:normal; }
@font-face { font-family: ff4; src: url("4.otf"); }
.f4 { font-family:ff4,sans-serif; font-weight:normal; font-style:normal; }
</style>
</head>
<body>
<img style="position:absolute; left:0px; top:0px;" width="595" height="793" src="page6.png"">
<div class="txt" style="position:absolute; left:37px; top:48px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">H. Nadeeshani, J. Li, T. Ying et al.</span></div>
<div class="txt" style="position:absolute; left:413px; top:48px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Journal of Advanced Research 37 (2022) 267–278</span></div>
<div class="txt" style="position:absolute; left:37px; top:69px;"><span class="f3" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Table 1 </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(</span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">continued</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">)</span></div>
<div class="txt" style="position:absolute; left:46px; top:83px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Therapeutic effect/age-related</span></div>
<div class="txt" style="position:absolute; left:46px; top:92px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">complication</span></div>
<div class="txt" style="position:absolute; left:46px; top:104px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Age-associated</span></div>
<div class="txt" style="position:absolute; left:55px; top:113px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">cerebromicrovascular</span></div>
<div class="txt" style="position:absolute; left:55px; top:121px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">dysfunction and cognitive decline</span></div>
<div class="txt" style="position:absolute; left:165px; top:83px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Model</span></div>
<div class="txt" style="position:absolute; left:165px; top:104px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Aged (24 months) C57BL/6 mice</span></div>
<div class="txt" style="position:absolute; left:321px; top:83px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN dose and</span></div>
<div class="txt" style="position:absolute; left:321px; top:92px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">duration</span></div>
<div class="txt" style="position:absolute; left:321px; top:104px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IP </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500 mg/kg body</span></div>
<div class="txt" style="position:absolute; left:321px; top:113px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">weight/day, 14 days</span></div>
<div class="txt" style="position:absolute; left:46px; top:164px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Rescuing female fertility during</span></div>
<div class="txt" style="position:absolute; left:55px; top:173px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">reproductive aging</span></div>
<div class="txt" style="position:absolute; left:165px; top:164px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Aged (12–14 months) C57BL/6 female mice</span></div>
<div class="txt" style="position:absolute; left:321px; top:164px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Drinking water </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">2</span></div>
<div class="txt" style="position:absolute; left:321px; top:173px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">g/L, 4 weeks</span></div>
<div class="txt" style="position:absolute; left:46px; top:207px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Therapeutic effect/age-</span></div>
<div class="txt" style="position:absolute; left:46px; top:216px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">related complication</span></div>
<div class="txt" style="position:absolute; left:144px; top:207px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Model</span></div>
<div class="txt" style="position:absolute; left:270px; top:207px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">NMN dose and</span></div>
<div class="txt" style="position:absolute; left:270px; top:216px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">duration</span></div>
<div class="txt" style="position:absolute; left:335px; top:207px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Effect</span></div>
<div class="txt" style="position:absolute; left:396px; top:83px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Effect</span></div>
<div class="txt" style="position:absolute; left:396px; top:103px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Restored NAD</span><span class="f1" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">levels mitochondrial</span></div>
<div class="txt" style="position:absolute; left:396px; top:113px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">energetic</span></div>
<div class="txt" style="position:absolute; left:396px; top:121px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Reduce oxidative stress</span></div>
<div class="txt" style="position:absolute; left:396px; top:130px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Reversed cerebrovascular endothelial</span></div>
<div class="txt" style="position:absolute; left:396px; top:138px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">dysfunction</span></div>
<div class="txt" style="position:absolute; left:396px; top:147px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Improved neurovascular coupling</span></div>
<div class="txt" style="position:absolute; left:396px; top:156px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">responses and cognitive performance</span></div>
<div class="txt" style="position:absolute; left:396px; top:163px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Restored NAD</span><span class="f1" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">levels and fertility</span></div>
<div class="txt" style="position:absolute; left:396px; top:173px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Rejuvenated oocyte quality</span></div>
<div class="txt" style="position:absolute; left:396px; top:181px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Supported the embryo development</span></div>
<div class="txt" style="position:absolute; left:396px; top:190px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">reversing the adverse consequences</span></div>
<div class="txt" style="position:absolute; left:396px; top:198px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">of elevated maternal age</span></div>
<div class="txt" style="position:absolute; left:46px; top:228px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Mitochondrial function and</span></div>
<div class="txt" style="position:absolute; left:55px; top:237px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">cardioprotection in</span></div>
<div class="txt" style="position:absolute; left:55px; top:245px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">myocardial ischemia/</span></div>
<div class="txt" style="position:absolute; left:55px; top:254px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">reperfusion injury</span></div>
<div class="txt" style="position:absolute; left:46px; top:271px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Promoting neurovascular</span></div>
<div class="txt" style="position:absolute; left:55px; top:280px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">rejuvenation</span></div>
<div class="txt" style="position:absolute; left:144px; top:228px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Aged Wistar rats (22–24 months old)</span></div>
<div class="txt" style="position:absolute; left:144px; top:271px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Aged (24 months) C57BL/6 mice</span></div>
<div class="txt" style="position:absolute; left:46px; top:314px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Oocyte quality reduction with</span></div>
<div class="txt" style="position:absolute; left:55px; top:322px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">advanced maternal age</span></div>
<div class="txt" style="position:absolute; left:144px; top:314px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Aged (64–68 weeks) ICR female mice</span></div>
<div class="txt" style="position:absolute; left:46px; top:365px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Werner syndrome</span></div>
<div class="txt" style="position:absolute; left:46px; top:408px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Ataxia telangiectasia</span></div>
<div class="txt" style="position:absolute; left:144px; top:365px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">young</span></div>
<div class="txt" style="position:absolute; left:144px; top:374px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">(Day 2) and old (Day 10) </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">wrn-1(gk99)</span></div>
<div class="txt" style="position:absolute; left:144px; top:382px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">and wild type N2 </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Caenorhabditis</span></div>
<div class="txt" style="position:absolute; left:144px; top:391px;"><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">elegans </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">and </span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Drosophila melanogaster</span></div>
<div class="txt" style="position:absolute; left:144px; top:400px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">worms</span></div>
<div class="txt" style="position:absolute; left:144px; top:408px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Ataxia-telangiectasia mutated</span></div>
<div class="txt" style="position:absolute; left:144px; top:415px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">B6;129S4-</span><span class="f2" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Atm</span><span class="f2" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">tm1Bal</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">/J mice</span></div>
<div class="txt" style="position:absolute; left:270px; top:228px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IP </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">100 mg/kg</span></div>
<div class="txt" style="position:absolute; left:270px; top:237px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">body weight/</span></div>
<div class="txt" style="position:absolute; left:270px; top:245px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">every other day,</span></div>
<div class="txt" style="position:absolute; left:270px; top:254px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">28 days</span></div>
<div class="txt" style="position:absolute; left:270px; top:271px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IP </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">500 mg/kg</span></div>
<div class="txt" style="position:absolute; left:270px; top:280px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">body weight/day,</span></div>
<div class="txt" style="position:absolute; left:270px; top:288px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">14 days</span></div>
<div class="txt" style="position:absolute; left:270px; top:314px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IP </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">200 mg/kg</span></div>
<div class="txt" style="position:absolute; left:270px; top:322px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">body weight/day,</span></div>
<div class="txt" style="position:absolute; left:270px; top:331px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">10 days</span></div>
<div class="txt" style="position:absolute; left:270px; top:365px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">1 mM from the L4</span></div>
<div class="txt" style="position:absolute; left:270px; top:374px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">stage</span></div>
<div class="txt" style="position:absolute; left:335px; top:228px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Enhanced hemodynamic parameters</span></div>
<div class="txt" style="position:absolute; left:335px; top:237px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Decreased dehydrogenase release and infarct size</span></div>
<div class="txt" style="position:absolute; left:335px; top:245px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Ameliorated mitochondrial membrane potential</span></div>
<div class="txt" style="position:absolute; left:335px; top:254px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Declined mitochondrial ROS and oxidative stress</span></div>
<div class="txt" style="position:absolute; left:335px; top:261px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Restored NAD</span><span class="f1" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+</span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">/NADH ratio</span></div>
<div class="txt" style="position:absolute; left:335px; top:271px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Promoted SIRT1activatio in the neurovascular unit</span></div>
<div class="txt" style="position:absolute; left:335px; top:280px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Reversed age-associated alterations in neurovascular</span></div>
<div class="txt" style="position:absolute; left:335px; top:288px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">transcriptome which predicted to be mediated by the</span></div>
<div class="txt" style="position:absolute; left:335px; top:297px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">involvement of genes in anti-apoptosis, anti-inﬂammatory</span></div>
<div class="txt" style="position:absolute; left:335px; top:305px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">and mitochondrial rejuvenation pathways</span></div>
<div class="txt" style="position:absolute; left:335px; top:313px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Restored NAD</span><span class="f1" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">levels</span></div>
<div class="txt" style="position:absolute; left:335px; top:322px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Increased ovulation, fertilisation capability and meiotic</span></div>
<div class="txt" style="position:absolute; left:335px; top:331px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">competency</span></div>
<div class="txt" style="position:absolute; left:335px; top:340px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Promoted cytoplasmic and nuclear maturation</span></div>
<div class="txt" style="position:absolute; left:335px; top:348px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Suppressed accumulation of DNA damage and ROS</span></div>
<div class="txt" style="position:absolute; left:335px; top:357px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Declined apoptosis</span></div>
<div class="txt" style="position:absolute; left:335px; top:365px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Extended lifespan and health-span</span></div>
<div class="txt" style="position:absolute; left:335px; top:374px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Improved proliferative potency and number of mitotic</span></div>
<div class="txt" style="position:absolute; left:335px; top:381px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">cells by the NAD</span><span class="f1" style="font-size:4px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">repletion</span></div>
<div class="txt" style="position:absolute; left:270px; top:408px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Drinking water </span><span class="f4" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">À</span></div>
<div class="txt" style="position:absolute; left:270px; top:417px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">12 mM, 2 weeks</span></div>
<div class="txt" style="position:absolute; left:335px; top:408px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Normalized neuromuscular function</span></div>
<div class="txt" style="position:absolute; left:335px; top:417px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Delayed memory loss</span></div>
<div class="txt" style="position:absolute; left:335px; top:425px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Extended lifespan</span></div>
<div class="txt" style="position:absolute; left:335px; top:434px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Stimulated neuronal DNA repair</span></div>
<div class="txt" style="position:absolute; left:335px; top:442px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Improve mitochondrial quality via mitophagy</span></div>
<div class="txt" style="position:absolute; left:37px; top:455px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">IP-Intraperitoneal.</span></div>
<div class="txt" style="position:absolute; left:519px; top:83px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Reference</span></div>
<div class="txt" style="position:absolute; left:519px; top:104px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[39]</span></div>
<div class="txt" style="position:absolute; left:519px; top:164px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[43]</span></div>
<div class="txt" style="position:absolute; left:519px; top:207px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">Reference</span></div>
<div class="txt" style="position:absolute; left:519px; top:228px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[40]</span></div>
<div class="txt" style="position:absolute; left:519px; top:271px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[37]</span></div>
<div class="txt" style="position:absolute; left:519px; top:314px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[42]</span></div>
<div class="txt" style="position:absolute; left:519px; top:365px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[52]</span></div>
<div class="txt" style="position:absolute; left:519px; top:408px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,127,173,1);">[54]</span></div>
<div class="txt" style="position:absolute; left:37px; top:473px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">associated gene expression in main metabolic organs, while</span></div>
<div class="txt" style="position:absolute; left:37px; top:483px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">enhancing mito-nuclear protein imbalance and mitochondrial</span></div>
<div class="txt" style="position:absolute; left:37px; top:494px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">oxidative metabolism in skeletal muscles. Guan et al. [31] elabo-</span></div>
<div class="txt" style="position:absolute; left:37px; top:504px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">rated that NMN supplementation restored reduced contents of</span></div>
<div class="txt" style="position:absolute; left:37px; top:513px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">renal protective molecule, SIRT1 and its cofactor, NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+</span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">. The height-</span></div>
<div class="txt" style="position:absolute; left:37px; top:524px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ened NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and SIRT1 levels in kidneys of aged mice protected aged</span></div>
<div class="txt" style="position:absolute; left:37px; top:536px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">kidneys from both ischemia–reperfusion- and cisplatin-induced</span></div>
<div class="txt" style="position:absolute; left:37px; top:546px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">acute kidney injuries.</span></div>
<div class="txt" style="position:absolute; left:49px; top:557px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">As explained by Li et al. [32], nudix homology domains (NHDs)</span></div>
<div class="txt" style="position:absolute; left:37px; top:565px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">are binding domains of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and through binding to them, NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">is</span></div>
<div class="txt" style="position:absolute; left:37px; top:577px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">able to regulate protein–protein interactions. The modulation of</span></div>
<div class="txt" style="position:absolute; left:37px; top:588px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">these interactions may lead to protecting the human body from</span></div>
<div class="txt" style="position:absolute; left:37px; top:598px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging, radiation and cancer. PARP1 is a critical protein that involves</span></div>
<div class="txt" style="position:absolute; left:37px; top:609px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in DNA repairing. The inhibition of PARP1 is prevented by binding</span></div>
<div class="txt" style="position:absolute; left:37px; top:618px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">to the NDH domain of DBC1 (deleted in breast cancer 1)</span></div>
<div class="txt" style="position:absolute; left:37px; top:628px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">nuclear protein. Nevertheless, when NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">concentration is</span></div>
<div class="txt" style="position:absolute; left:37px; top:640px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">reduced with the age, DBC1 is progressively bound to PARP1, lead-</span></div>
<div class="txt" style="position:absolute; left:37px; top:651px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">ing to accumulate DNA damage. This process of DNA damage can</span></div>
<div class="txt" style="position:absolute; left:37px; top:660px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">be reversed by restoring NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in the body. Results of this</span></div>
<div class="txt" style="position:absolute; left:37px; top:672px;"><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">study showed that, NMN treatment increased hepatic</span></div>
<div class="txt" style="position:absolute; left:37px; top:681px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">contents, disrupted DBC1-PARP1 complex, reduced DNA</span></div>
<div class="txt" style="position:absolute; left:37px; top:693px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">damage and defended against changes in haemoglobin and white</span></div>
<div class="txt" style="position:absolute; left:37px; top:703px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">blood cell count including lymphocytes.</span></div>
<div class="txt" style="position:absolute; left:49px; top:713px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Tsubota [33] showed that NMN, as a sirtuins activating agent</span></div>
<div class="txt" style="position:absolute; left:37px; top:724px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">had protective effects against age-related ocular diseases such as</span></div>
<div class="txt" style="position:absolute; left:37px; top:734px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">glaucoma, dry eye and macular degeneration. As elaborated by</span></div>
<div class="txt" style="position:absolute; left:37px; top:745px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Das et al. [34], reduction of blood ﬂow and capillary density with</span></div>
<div class="txt" style="position:absolute; left:306px; top:473px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">aging is a main cause of morbidity and mortality, whereas NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:482px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">as a NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">precursor can reverse these to a certain extent by trig-</span></div>
<div class="txt" style="position:absolute; left:306px; top:494px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">gering sirtuin deacylases (SIRT1-7). NMN supplementation could</span></div>
<div class="txt" style="position:absolute; left:306px; top:504px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">increase NAD levels in liver and gastrocnemius tissues by nearly</span></div>
<div class="txt" style="position:absolute; left:306px; top:515px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">5 and 1 folds, respectively. Johnson et al. [35] observed that</span></div>
<div class="txt" style="position:absolute; left:306px; top:525px;"><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">occurrence of age-associated cognitive and behavioural dys-</span></div>
<div class="txt" style="position:absolute; left:306px; top:534px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">functions was induced by declined NAMPT-mediated NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">biosyn-</span></div>
<div class="txt" style="position:absolute; left:306px; top:544px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">thesis causing 40% gradual decrease of NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels in the</span></div>
<div class="txt" style="position:absolute; left:306px; top:557px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">hippocampus, predominately in CA1 region. It showed that, even</span></div>
<div class="txt" style="position:absolute; left:306px; top:565px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">by short term supplementation of NMN, NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">levels could be</span></div>
<div class="txt" style="position:absolute; left:306px; top:577px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">restored, while mitigating the age-related changes in the sensory</span></div>
<div class="txt" style="position:absolute; left:306px; top:588px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">processing of hypersensitivity, several other aversive stimuli and</span></div>
<div class="txt" style="position:absolute; left:306px; top:598px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">other associated behaviours, enhancing the quality of later lives.</span></div>
<div class="txt" style="position:absolute; left:306px; top:609px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">A prospective downstream effector was identiﬁed, namely,</span></div>
<div class="txt" style="position:absolute; left:306px; top:619px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">calcium/calmodulin-dependent serine protein kinase, which got</span></div>
<div class="txt" style="position:absolute; left:306px; top:628px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">reduced in hippocampus along with age-related NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">drop. The</span></div>
<div class="txt" style="position:absolute; left:306px; top:640px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">promoter activity of this effector was regulated in a SIRT1 reliant</span></div>
<div class="txt" style="position:absolute; left:306px; top:651px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">manner, while its expression could be enhanced by NMN</span></div>
<div class="txt" style="position:absolute; left:306px; top:661px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">supplementation.</span></div>
<div class="txt" style="position:absolute; left:318px; top:672px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">Hosseini et al. [36] reported that </span><span class="f2" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">in vivo </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">intraperitoneal injec-</span></div>
<div class="txt" style="position:absolute; left:306px; top:682px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">tion of NMN and NMN together with melatonin stimulated neuro-</span></div>
<div class="txt" style="position:absolute; left:306px; top:693px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">protective effects and alleviated age-associated memory and</span></div>
<div class="txt" style="position:absolute; left:306px; top:703px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">learning impairments. Furthermore, the administration of them</span></div>
<div class="txt" style="position:absolute; left:306px; top:713px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">separately or in combination enhanced mitochondrial function</span></div>
<div class="txt" style="position:absolute; left:306px; top:724px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">and decreased apoptosis cell count both in hippocampus and pre-</span></div>
<div class="txt" style="position:absolute; left:306px; top:734px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">frontal cortex regions of aged rats. Kiss et al. [37] illustrated that</span></div>
<div class="txt" style="position:absolute; left:306px; top:743px;"><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">age-associated NAD</span><span class="f1" style="font-size:5px;vertical-align:super;color:rgba(0,0,0,1);">+ </span><span class="f1" style="font-size:7px;vertical-align:baseline;color:rgba(0,0,0,1);">decline was linked with mis-regulation of</span></div>
<div class="txt" style="position:absolute; left:291px; top:764px;"><span class="f1" style="font-size:6px;vertical-align:baseline;color:rgba(0,0,0,1);">272</span></div>
</body>
</html>
